A new perspective on the interaction between the Vg/VGLL1-3 proteins and the TEAD transcription factors.

Mesrouze, Yannick; Aguilar, Gustavo; Bokhovchuk, Fedir; Martin, Typhaine; Delaunay, Clara; Villard, Frédéric; Meyerhofer, Marco; Zimmermann, Catherine; Fontana, Patrizia; Wille, Roman; Vorherr, Thomas; Erdmann, Dirk; Furet, Pascal; Scheufler, Clemens; Schmelzle, Tobias; Affolter, Markus; Chène, Patrick

Mesrouze, Yannick; Aguilar, Gustavo; Bokhovchuk, Fedir; Martin, Typhaine; Delaunay, Clara; Villard, Frédéric; Meyerhofer, Marco; Zimmermann, Catherine; Fontana, Patrizia; Wille, Roman; Vorherr, Thomas; Erdmann, Dirk; Furet, Pascal; Scheufler, Clemens; Schmelzle, Tobias; Affolter, Markus; Chène, Patrick.

Affiliation

Mesrouze Y; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
Aguilar G; Biozentrum, University of Basel, Klingelbergstrasse 50/70, 4056, Basel, Switzerland.
Bokhovchuk F; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
Martin T; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
Delaunay C; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
Villard F; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Meyerhofer M; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
Zimmermann C; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
Fontana P; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
Wille R; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Vorherr T; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Erdmann D; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
Furet P; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Scheufler C; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Schmelzle T; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland.
Affolter M; Biozentrum, University of Basel, Klingelbergstrasse 50/70, 4056, Basel, Switzerland.
Chène P; Disease Area Oncology, Novartis Institutes for Biomedical Research, Novartis, WSJ 386 4.02.01, 4002, Basel, Switzerland. patrick_chene@yahoo.com.

Sci Rep ; 10(1): 17442, 2020 10 15.

Article de En | MEDLINE | ID: mdl-33060790

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteurs de transcription / Protéines nucléaires / Protéines de liaison à l'ADN / Protéines du muscle Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Sci Rep Année: 2020 Type de document: Article Pays d'affiliation: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google